Neoadjuvant chemotherapy carboplatin - taxane response in locally advanced triple negative breast cancer patients in relation to molecular biomarkers

被引：0
|
作者：
Sad, L. M. [1 ]
Younis, S. [1 ]
Abd El Hak, M. [2 ]
机构：
[1] Tanta Univ Hosp, Oncol, Tanta, Egypt
[2] Tanta Univ Hosp, Pathol, Tanta, Egypt
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw365.73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
294P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Differential response of neoadjuvant chemotherapy with taxane-carboplatin versus taxane-epirubicin in patients with locally advanced triple-negative breast cancer.
    Wang, Jiayu
    Xu, Binghe
    Li, Qing
    Zhang, Pin
    Yuan, Peng
    Ma, Fei
    Fan, Ying
    Luo, Yang
    Cai, Ruigang
    Li, Qiao
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Neoadjuvant carboplatin and docetaxel in locally advanced triple negative breast cancer: A Hispanic trial
    Gomez, Saul Campos
    Gomez, Karen Angelica Campos
    Garces, Marciela Garcia
    Morelos, Gladys
    Alvarez, Jesus Hernandez
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer
    Somlo, G.
    Chung, S.
    Frankel, P.
    Hurria, A.
    Koehler, S.
    Kruper, L.
    Mortimer, J. E.
    Paz, B.
    Robinson, K.
    Taylor, L.
    Vito, C.
    Waisman, J.
    Yeon, C.
    Yim, J.
    Yuan, Y.
    Tong, T.
    CANCER RESEARCH, 2016, 76
  • [4] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [5] Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer
    Kim, Seung Il
    Sohn, Joohyuk
    Koo, Ja Seung
    Park, Se Ho
    Park, Hyung Seok
    Park, Byeong Woo
    ONCOLOGY, 2010, 79 (5-6) : 324 - 330
  • [6] Phase II trial of neoadjuvant carboplatin and nab-paclitaxel in patients with locally advanced triple negative breast cancer
    Yuan, Y.
    Frankel, P.
    Li, M.
    Kruper, L.
    Jones, V.
    Treece, T.
    Waisman, J.
    Yim, J.
    Tumyan, L.
    Schmolze, D.
    Hurria, A.
    Yeon, C.
    Mortimer, J.
    Somlo, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [8] Induction chemotherapy for patients with Locally advanced triple negative breast cancer.
    Ignatova, Ekaterina
    Frolova, Mona
    Stenina, Marina B.
    Petrovsky, Alexander
    Tjulandin, Sergei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [9] Locally advanced triple negative breast cancer arising from fibroadenoma with complete response to neoadjuvant chemotherapy: A case report
    Shiino, Sho
    Yoshida, Masayuki
    Tokura, Momoko
    Watase, Chikashi
    Murata, Takeshi
    Jimbo, Kenjiro
    Takayama, Shin
    Suto, Akihiko
    Satomi, Kaishi
    Maeshima, Akiko Miyagi
    Kikuchi, Mari
    Uchiyama, Nachiko
    Kinoshita, Takayuki
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2020, 68 : 234 - 238
  • [10] Molecular biomarkers to predict neoadjuvant chemotherapy response in breast cancer patients treated with weekly paclitaxel plus carboplatin
    Chen, X. S.
    Wu, J. Y.
    Shen, K. W.
    Lu, H. F.
    Lu, J. S.
    Wu, J.
    Shao, Z. M.
    Shen, Z. Z.
    EJC SUPPLEMENTS, 2010, 8 (03): : 88 - 89
12345